These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 16307738

  • 1. Effects of fasudil, a Rho-kinase inhibitor, on myocardial preconditioning in anesthetized rats.
    Demiryürek S, Kara AF, Celik A, Babül A, Tarakçioglu M, Demiryürek AT.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):129-40. PubMed ID: 16307738
    [Abstract] [Full Text] [Related]

  • 2. Effects of Y-27632, a selective Rho-kinase inhibitor, on myocardial preconditioning in anesthetized rats.
    Demiryürek S, Kara AF, Celik A, Tarakçioğlu M, Bağci C, Demiryürek AT.
    Biochem Pharmacol; 2005 Jan 01; 69(1):49-58. PubMed ID: 15588713
    [Abstract] [Full Text] [Related]

  • 3. Effects of chronic trimetazidine treatment on myocardial preconditioning in anesthetized rats.
    Kara AF, Demiryürek S, Celik A, Tarakçioğlu M, Demiryürek AT.
    Fundam Clin Pharmacol; 2006 Oct 01; 20(5):449-59. PubMed ID: 16968415
    [Abstract] [Full Text] [Related]

  • 4. Effects of trimetazidine on myocardial preconditioning in anesthetized rats.
    Kara AF, Demiryürek S, Celik A, Tarakçioğlu M, Demiryürek AT.
    Eur J Pharmacol; 2004 Oct 25; 503(1-3):135-45. PubMed ID: 15496308
    [Abstract] [Full Text] [Related]

  • 5. Acute vasodilator effect of fasudil, a Rho-kinase inhibitor, in monocrotaline-induced pulmonary hypertension in rats.
    Jiang BH, Tawara S, Abe K, Takaki A, Fukumoto Y, Shimokawa H.
    J Cardiovasc Pharmacol; 2007 Feb 25; 49(2):85-9. PubMed ID: 17312448
    [Abstract] [Full Text] [Related]

  • 6. The potential antiarrhythmic effects of exogenous and endogenous bradykinin in the ischaemic rat heart in vivo.
    Sun W, Wainwright CL.
    Coron Artery Dis; 1994 Jun 25; 5(6):541-50. PubMed ID: 7952414
    [Abstract] [Full Text] [Related]

  • 7. High-dose fasudil preserves postconditioning against myocardial infarction under hyperglycemia in rats: role of mitochondrial KATP channels.
    Ichinomiya T, Cho S, Higashijima U, Matsumoto S, Maekawa T, Sumikawa K.
    Cardiovasc Diabetol; 2012 Mar 22; 11():28. PubMed ID: 22436066
    [Abstract] [Full Text] [Related]

  • 8. Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in rats.
    Li F, Xia W, Li A, Zhao C, Sun R.
    Pharmacol Res; 2007 Jan 22; 55(1):64-71. PubMed ID: 17127075
    [Abstract] [Full Text] [Related]

  • 9. N-2-mercaptopropionylglycine, a scavanger of reactive oxygen species, does not modify the early antiarrhythmic effect of ischaemic preconditioning in anaesthetised dogs.
    Agnes H, Nagy L, Parratt JR, Papp J, Végh A.
    Cardiovasc Drugs Ther; 2004 Nov 22; 18(6):449-59. PubMed ID: 15770432
    [Abstract] [Full Text] [Related]

  • 10. Anti-ischemic effects of fasudil, a specific Rho-kinase inhibitor, in patients with stable effort angina.
    Fukumoto Y, Mohri M, Inokuchi K, Ito A, Hirakawa Y, Masumoto A, Hirooka Y, Takeshita A, Shimokawa H.
    J Cardiovasc Pharmacol; 2007 Mar 22; 49(3):117-21. PubMed ID: 17414222
    [Abstract] [Full Text] [Related]

  • 11. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina.
    Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M, Takeshita A.
    Circulation; 2002 Apr 02; 105(13):1545-7. PubMed ID: 11927519
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice.
    Wang YX, da Cunha V, Martin-McNulty B, Vincelette J, Li W, Choy DF, Halks-Miller M, Mahmoudi M, Schroeder M, Johns A, Light DR, Dole WP.
    Eur J Pharmacol; 2005 Apr 11; 512(2-3):215-22. PubMed ID: 15840407
    [Abstract] [Full Text] [Related]

  • 13. Vasodilator effects of fasudil, a Rho-kinase inhibitor, on retinal arterioles in stroke-prone spontaneously hypertensive rats.
    Okamura N, Saito M, Mori A, Sakamoto K, Kametaka S, Nakahara T, Ishii K.
    J Ocul Pharmacol Ther; 2007 Jun 11; 23(3):207-12. PubMed ID: 17593003
    [Abstract] [Full Text] [Related]

  • 14. Fasudil, a Rho kinase (ROCK) inhibitor, protects against ischemic neuronal damage in vitro and in vivo by acting directly on neurons.
    Yamashita K, Kotani Y, Nakajima Y, Shimazawa M, Yoshimura S, Nakashima S, Iwama T, Hara H.
    Brain Res; 2007 Jun 18; 1154():215-24. PubMed ID: 17482584
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological profile of hydroxy fasudil as a selective rho kinase inhibitor on ischemic brain damage.
    Satoh S, Utsunomiya T, Tsurui K, Kobayashi T, Ikegaki I, Sasaki Y, Asano T.
    Life Sci; 2001 Aug 10; 69(12):1441-53. PubMed ID: 11531167
    [Abstract] [Full Text] [Related]

  • 16. Long-term administration of rho-kinase inhibitor ameliorates renal damage in malignant hypertensive rats.
    Ishikawa Y, Nishikimi T, Akimoto K, Ishimura K, Ono H, Matsuoka H.
    Hypertension; 2006 Jun 10; 47(6):1075-83. PubMed ID: 16636194
    [Abstract] [Full Text] [Related]

  • 17. Administration of the Rho-kinase inhibitor fasudil before ischemia or just after reperfusion, but not 30 min after reperfusion, protects the stunned myocardium in swine.
    Shibata I, Yoshitomi O, Use T, Ureshino H, Cho S, Maekawa T, Hara T, Sumikawa K.
    Cardiovasc Drugs Ther; 2008 Aug 10; 22(4):293-8. PubMed ID: 18470606
    [Abstract] [Full Text] [Related]

  • 18. Expression of Rho-kinase (ROCK-1 and ROCK-2) and its substantial role in the contractile activity of the sheep ureter.
    Levent A, Büyükafsar K.
    Br J Pharmacol; 2004 Oct 10; 143(3):431-7. PubMed ID: 15351780
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of Rho-kinase attenuates nephrosclerosis and improves survival in salt-loaded spontaneously hypertensive stroke-prone rats.
    Nishikimi T, Koshikawa S, Ishikawa Y, Akimoto K, Inaba C, Ishimura K, Ono H, Matsuoka H.
    J Hypertens; 2007 May 10; 25(5):1053-63. PubMed ID: 17414670
    [Abstract] [Full Text] [Related]

  • 20. Cardioprotective effects of low-dose combination therapy with rosuvastatin and fasudil in the isolated rat heart.
    Wu N, Li W, Lv Y, Shu W, Jia D.
    Pharmazie; 2014 Sep 10; 69(9):704-8. PubMed ID: 25272944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.